The Cooper Companies, Inc. ( COO) - Stock Earnings
COO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Dec. 3, 2026, midnight | — / — | — | — / — | — |
COO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 130.8 million USD | 1.0 billion USD |
| 2026Q1 | -77.9 million USD | 1.1 billion USD |
| 2026Q2 | 432.8 million USD | 1.1 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
COO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 294.2 million USD | 3.6 billion USD |
| 2024 | 392.3 million USD | 3.9 billion USD |
| 2025 | 374.9 million USD | 4.1 billion USD |
| 2026 Est. | — | — |
COO
Price: $60.92
Earnings Per Share: 2.91 USD
P/E Ratio: 18.63
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 261400
Ebitda: 153.9 millionMarket Capitalization: 11.7 billion
Average Dividend Frequency: 2